BiomX Inc.
AMEXPHGE enters the week of May 6 carrying one of the most unusual stories in small-cap biotech: a company nominally still in the phage-therapy space is now best known for its Israeli AI defence subsidiary, while its stock is down more than 80% in a month and a director just pocketed $8.25 million selling into the slide. The price action is the story's opening act. PHGE closed at $0.68…
PHGE short interest surged 126% over the past week to 15.3% of float, while utilization jumped to 72% and cost to borrow stands at 270%.
Snapshot as of 7 May 2026
PHGE enters the week of May 6 carrying one of the most unusual stories in small-cap biotech: a company nominally still in the phage-therapy space is now best known for its Israeli AI defence subsidiary, while its stock…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PHGE — free to start on ORTEX.
Sign up for free →Open PHGE on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live PHGE data →